Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.4600 (-1.82%) ($9.4600 - $9.4600) on Wed. May. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 61 | Latest Price | $9.4600(-1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(64%) IBB(50%) IWC(49%) IWM(45%) IWO(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.415% in a week (0% probabilities). IGOV(-14%) TBT(-12%) UUP(-8%) VXX(-7%) VIXM(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $9.5(-0.42%) | 10 Day Moving Average | $9.57(-1.15%) | 20 Day Moving Average | $9.28(1.94%) | To recent high | -8.4% | To recent low | 48.9% | Market Cap | $588m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |